Live Chat

Giao dịch Bristol Myers BMY

BristolMyers biểu đồ trực tiếp

Hiểu biết sâu sắc

Weekly Search
Weekly
Daily
Ngày Đóng Thay đổi % Thay đổi Mở Cao Thấp

Tin tức

Thông tin

Chênh lệch

0.33

Tỷ lệ Spread (%)

0.6312 %

Đòn bẩy

1:10

Lãi suất Qua đêm Mua

-0.0597 %

Lãi suất Qua đêm Bán

-0.0292 %

Forex

USD

Giờ giao dịch

Thị trường đã đóng cửa.

Thứ sáu

13:31 - 19:59

Thứ hai

13:31-19:59

Thứ ba

13:31-19:59

Thứ tư

13:31-19:59

Thứ năm

13:31-19:59

Báo cáo thu nhập

Mở

---

Đóng trước đó

---

52 Tuần Cao/Thấp

--- – ---

Giá trị vốn hóa thị trường

106397949952

Cổ phiếu nổi bật

2027399936

Ngày báo cáo thu nhập (tiếp theo)

2001-08-07

Tỷ suất cổ tức

2024-11-01

Ngày giao dịch không hưởng quyền

2024-10-04

Tỷ lệ cổ tức thường niên kỳ hạn

2.4

Tỷ suất cổ tức thường niên kỳ hạn

0.0449

EPS

-3.25

Cổ phiếu nổi bật

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Tìm hiểu thêm về công cụ này

Các công cụ liên quan

Markets.com news

Keep up with the news as it happens and know what’s impacting the markets at any time.

Wall Street's leading indices notch fresh records ahead of US inflation data release later today

Thứ năm, 10 Tháng Mười 2024

Wall St. soars to new highs ahead of US inflation report

Thứ tư, 9 Tháng Mười 2024

Hang Seng index surges, breaking 21,000 mark

Thứ tư, 9 Tháng Mười 2024

Dow Jones index today: Dow Hit Record Closing Highs

Thứ tư, 9 Tháng Mười 2024

Nvidia stock surges 4% in Tuesday, notching its fifth straight day of gains

Live Chat